Skip to main content
Equibles
INKT logo

INKT · MiNK Therapeutics, Inc. · Exempt Offerings

Track INKT — free

Use INKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.34 -0.19 (-1.99%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Nov 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Because the completion of anticipated funding is not entirely within our control, we are required to disclose that substantial doubt exists about our ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”
View the 10-Q filed Nov 12, 2026
Market Cap
$47.95M
Shares
5.13M
Volume · Nov 13 19.03K Avg daily vol (3M) 14.64K

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.

Key facts CIK 1840229 CUSIP 603693201 13F (30d) 32 filings 23 filers Visit website Investor relations